1. Notch1 and PI3K/Akt signaling blockers DAPT and LY294002 coordinately inhibit metastasis of gastric cancer through mutual enhancement
    Xingchun Peng et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
  2. Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
    Pravita Balijepalli et al, 2021, Cells CrossRef
  3. MicroRNA miR-1275 coordinately regulates AEA/LPA signals via targeting FAAH in lipid metabolism reprogramming of gastric cancer
    Qian Yang et al, 2023, Cell Death & Disease CrossRef

  4. Curcumin Affects Gastric Cancer Cell Migration, Invasion and Cytoskeletal Remodeling Through Gli1-β-Catenin


    Xiao Zhang et al, 2020, Cancer Management and Research CrossRef
  5. Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer
    null Kaffe et al, 2019, Cancers CrossRef
  6. Downregulation of acylglycerol kinase suppresses high-glucose-induced endothelial-mesenchymal transition in human retinal microvascular endothelial cells through regulating the LPAR1/TGF-β/Notch signaling pathway
    Haijing Wang et al, 2022, Canadian Journal of Physiology and Pharmacology CrossRef
  7. LPAR2-mediated action promotes human renal cell carcinoma via MAPK/NF-κB signaling to regulate cytokine network
    Yuewu Wang et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
  8. Integration of an LPAR1 Antagonist into Liposomes Enhances Their Internalization and Tumor Accumulation in an Animal Model of Human Metastatic Breast Cancer
    Rudolf G. Abdelmessih et al, 2023, Molecular Pharmaceutics CrossRef
  9. Unraveling the Molecular Nexus between GPCRs, ERS, and EMT
    Niti Kumari et al, 2021, Mediators of Inflammation CrossRef
  10. Deregulation of lysophosphatidic acid metabolism in oral cancer promotes cell migration via the up-regulation of COX-2
    Mariati Abdul Rahman et al, 2020, PeerJ CrossRef
  11. Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression via EGFR-PI3K/Aurora-AThr288-geminin dual signaling pathways
    Haile Zhao et al, 2022, Frontiers in Pharmacology CrossRef
  12. KAI1/CD82gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers
    Shuo Wang et al, 2022, World Journal of Gastrointestinal Oncology CrossRef
  13. Carbon-coated selenium nanoparticles for photothermal therapy in choriocarcinoma cells
    Hui Yu et al, 2024, RSC Advances CrossRef
  14. Role of Hippo-YAP Signaling in Osseointegration by Regulating Osteogenesis, Angiogenesis, and Osteoimmunology
    Anqi Zhou et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
  15. Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
    Yan Xu, 2019, Cancers CrossRef
  16. Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
    Yu-Hsuan Lin et al, 2021, Cells CrossRef
  17. Lysophosphatidic Acid–Induced EGFR Transactivation Promotes Gastric Cancer Cell DNA Replication by Stabilizing Geminin in the S Phase
    Haile Zhao et al, 2021, Frontiers in Pharmacology CrossRef
  18. Dynamic actin remodeling in response to lysophosphatidic acid
    Saima S. Mir et al, 2020, Journal of Biomolecular Structure and Dynamics CrossRef